TG Therapeutics NASDAQ: TGTX Chairman, President and Chief Executive Officer Mike Weiss said the com

California State Teachers Retirement System lifted its holdings in shares of TG Therapeutics, Inc. (

Fireside chat scheduled for Monday, September 14, 2026, at 12:00pm ET Fireside chat scheduled for Mo

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced th

TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock?

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy

TG Therapeutics, Inc.'s Q4 2026/H1 2027 will be rich in catalysts. From the presentation of prelimin

Deutsche Bank AG purchased a new stake in TG Therapeutics, Inc. (NASDAQ: TGTX) in the undefined quar

Shares of TG Therapeutics rose this week after buyout rumors surfaced. TG is a prime takeover target

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w

Bank of America Corp DE lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 71.7% in the

Assenagon Asset Management S.A. decreased its holdings in shares of TG Therapeutics, Inc. (NASDAQ: T

TG Therapeutics, Inc. (NASDAQ: TGTX - Get Free Report) has earned an average rating of "Hold" from t

JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raise

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its nove

Empowered Funds LLC lifted its position in TG Therapeutics, Inc. (NASDAQ: TGTX) by 49.9% in the unde

TG Therapeutics, Inc. remains a Buy as BRIUMVI's momentum supports a durable, growing multiple scler

TG Therapeutics misses Q2 earnings estimates, but surging Briumvi demand lifts revenues y/y and prom

TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript

The headline numbers for TG Therapeutics (TGTX) give insight into how the company performed in the q

TG Therapeutics NASDAQ: TGTX reported second-quarter 2026 revenue of $240 million and raised its ful

TG Therapeutics (TGTX) came out with quarterly earnings of $0.05 per share, missing the Zacks Consen

TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $925.000 million to $950.000 million

TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.05 per share which missed the analys

Second quarter 2026 total global revenue of approximately $240 million, including BRIUMVI U.S. net p

B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b

US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY

https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2025-new-safety-

Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel

TCOM: -11% | Trip.com Group shares are trading lower after the company announce it is under investig

Retail investors are preparing for another busy week of earnings season with more than 1,600 compani

Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial re